Third, ANXA2 promotes the progression of ESCC through TTK and a series of related factors, including the Akt/mTOR signaling pathway and EMT-related proteins such as β-catenin, Snail and Claudin-1. Here, ANXA2 is linked to esophageal squamous cell carcinoma.